Gilead Sciences (GILD) Inventory Average (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Inventory Average data on file, last reported at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 6.31% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 6.31% YoY), and the FY2025 full-year result was $1.7 billion, changed 0.37% from the prior year.
• Inventory Average for Q1 2026 stood at $1.8 billion, up from $1.8 billion in the prior quarter.
• Across five years, Inventory Average topped out at $1.9 billion in Q3 2024 and bottomed at $1.5 billion in Q3 2022.
• The 5-year median for Inventory Average is $1.7 billion (2025), against an average of $1.7 billion.
• The widest annual swing landed in 2022, when Inventory Average dropped 16.19%; it then grew 20.88% in 2024.
• A 5-year view of Inventory Average shows it stood at $1.5 billion in 2022, then rose by 16.16% to $1.7 billion in 2023, then increased by 3.74% to $1.8 billion in 2024, then retreated by 0.56% to $1.8 billion in 2025, then advanced by 3.62% to $1.8 billion in 2026.
• The last three Inventory Average figures came in at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.

Peer Comparison